183 results on '"Agüera, Eduardo"'
Search Results
2. Neuroprotective and antioxidant effects of docosahexaenoic acid (DHA) in an experimental model of multiple sclerosis
3. Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action
4. SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19
5. Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosis
6. Illness-related uncertainty and patient experience in relapsing-remitting multiple sclerosis Spanish cohort
7. Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019
8. Author Correction: Genomic surveillance of enterovirus associated with aseptic meningitis cases in southern Spain, 2015–2018
9. Genomic surveillance of enterovirus associated with aseptic meningitis cases in southern Spain, 2015–2018
10. Denervated muscle extract promotes recovery of muscle atrophy through activation of satellite cells. An experimental study
11. Follow-Up Findings in Multiple System Atrophy from [123I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study
12. Effect of the Combination of Different Therapies on Oxidative Stress in the Experimental Model of Multiple Sclerosis
13. Diagnostic Effectiveness of [123I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy
14. Transcranial magnetic stimulation modifies astrocytosis, cell density and lipopolysaccharide levels in experimental autoimmune encephalomyelitis
15. Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis.
16. Follow-Up Findings in Multiple System Atrophy from [ 123 I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study.
17. Impact of Early-stage Relapsing Remitting Multiple Sclerosis on Quality of Life (P13-3.006)
18. Threatening Illness Perception and Associated Factors in Early-stage Relapsing Remitting Multiple Sclerosis (P9-3.017)
19. Symptom Severity in Early-stage Relapsing Remitting Multiple Sclerosis (P5-3.009)
20. Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach
21. Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis
22. Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model
23. Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis
24. The ultrastructure of muscle fibers and satellite cells in experimental autoimmune encephalomyelitis after treatment with transcranial magnetic stimulation
25. Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis
26. Mechanisms Involved in Neuroprotective Effects of Transcranial Magnetic Stimulation
27. Diagnostic Effectiveness of [ 123 I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy.
28. Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
29. Measuring productivity loss in early relapsing-remitting multiple sclerosis
30. Melatonin improves 3-nitropropionic acid induced behavioral alterations and neurotrophic factors levels
31. Transcranial Magnetic Stimulation Improves Muscle Involvement in Experimental Autoimmune Encephalomyelitis
32. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
33. Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis
34. Realidad actual de la aplicación de EMT a los trastornos neurodegenerativos y neuropsiquiátricos
35. Identification of patients with relapsing multiple sclerosis eligible for high-efficacy therapies
36. Assyrian reliefs as a source of equinotechnical documentation
37. Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress
38. Quantitative changes in the testicular structure in mice exposed to low doses of cadmium
39. Clinical and Neurochemical Effects of Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis: A Study Protocol for a Randomized Clinical Trial
40. Impact of Repetitive Transcranial Magnetic Stimulation on Neurocognition and Oxidative Stress in Relapsing-Remitting Multiple Sclerosis: A Case Report
41. The effect of prioritization over cognitive-motor interference in people with relapsing-remitting multiple sclerosis and healthy controls
42. Perceived illness-related uncertainty among patients with mid-stage relapsing-remitting multiple sclerosis
43. Extra-Virgin Olive Oil Modifies the Changes Induced in Non-Nervous Organs and Tissues by Experimental Autoimmune Encephalomyelitis Models
44. Implications of Vitamin D in Multiple Sclerosis and Other Neurodegenerative Processes: Bibliometric Analysis and Systematic Review
45. Muscular hypertrophy and atrophy in normal rats provoked by the administration of normal and denervated muscle extracts
46. Effects of transcranial magnetic stimulation on oxidative stress in experimental autoimmune encephalomyelitis
47. Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model
48. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab
49. Buenas prácticas de innovación docente en la Universidad de Córdoba
50. Skeletal muscle findings in experimental autoimmune encephalomyelitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.